TY  - GEN
TI  - Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group
SN  - 0003-9950
PY  - 1997///0821
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Choroid
KW  - blood supply
KW  - Choroid Diseases
KW  - diagnosis
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Fluorescein Angiography
KW  - Follow-Up Studies
KW  - Fundus Oculi
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Macular Degeneration
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Neovascularization, Pathologic
KW  - Recombinant Proteins
KW  - Safety
KW  - Treatment Outcome
KW  - Visual Acuity
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1001/archopht.1997.01100160035005
ER  -